Sky Medical Technology Ltd has developed the OnPulseTM technology platform, which has been proven to significantly improve blood ﬂow, both volume and velocity.
The results indicate that the platform can be used across a variety of medical indications, challenging both pharmaceutical and device solutions currently in use by healthcare providers today.
The primary initial applications for the technology are:
- Prevention and treatment of Deep Vein Thrombosis (DVT);
- Surgical recovery;
- Chronic wound care (of ‘hard to heal’ wounds); and
- Elite sports recovery.
|Product||Technology Growth EIS|
|Aim of funding||Growth|
|HMRC Advanced Assurance received||Yes|
|Envisaged investor exit||4-5 years|
|Targeted return||In excess of 4x capital invested|